Post-extubation Boussignac CPAP System in Adults With Moderate to Severe Obstructive Sleep Apnea
Launched by KINGSTON HEALTH SCIENCES CENTRE · Jun 13, 2013
Trial Information
Current as of April 30, 2025
Terminated
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • -\> 18 years of age
- • ASA II-IV
- • Previous diagnosis of moderate to severe obstructive sleep apnea
- • diagnosed via polysomnography
- • BMI \< 40
- • scheduled for an abdominal or peripheral surgical procedure requiring endotracheal intubation and admission to hospital
- Exclusion Criteria:
- • BMI \> 40
- • Age \<18 years
- • inability to provide signed informed consent
- • intra-thoracic
- • head or neck surgery
- • contraindication for immediate post-extubation application of CPAP
- • not expected to be eligible for timely extubation following the surgical procedure
About Kingston Health Sciences Centre
Kingston Health Sciences Centre (KHSC) is a leading academic health sciences organization dedicated to advancing patient care through innovative research and clinical trials. Located in Kingston, Ontario, KHSC combines the expertise of its hospitals and research facilities to foster collaboration among healthcare professionals, researchers, and industry partners. With a strong focus on translating research findings into effective treatments, KHSC is committed to improving health outcomes and enhancing the quality of life for patients. The center’s robust clinical trial program supports a diverse range of therapeutic areas, ensuring a comprehensive approach to healthcare innovation.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kingston, Ontario, Canada
Patients applied
Trial Officials
Kim E Turner, MD, FRCPC
Principal Investigator
Queen's University & Kingston General Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials